
Onto Innovation (ONTO) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
253.6M
Gross Profit
122.1M
48.16%
Operating Income
38.5M
15.17%
Net Income
33.9M
13.37%
EPS (Diluted)
$0.69
Balance Sheet Metrics
Total Assets
2.1B
Total Liabilities
195.4M
Shareholders Equity
1.9B
Debt to Equity
0.10
Cash Flow Metrics
Operating Cash Flow
81.1M
Free Cash Flow
83.7M
Revenue & Profitability Trend
Onto Innovation Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 987.3M | 815.9M | 1.0B | 788.9M | 556.5M |
Cost of Goods Sold | 472.0M | 395.6M | 466.0M | 359.8M | 278.0M |
Gross Profit | 515.3M | 420.3M | 539.2M | 429.1M | 278.5M |
Gross Margin % | 52.2% | 51.5% | 53.6% | 54.4% | 50.0% |
Operating Expenses | |||||
Research & Development | 116.8M | 104.4M | 112.0M | 96.1M | 84.6M |
Selling, General & Administrative | 162.0M | 144.9M | 135.3M | 125.2M | 113.4M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 278.8M | 249.4M | 247.2M | 221.3M | 198.0M |
Operating Income | 187.1M | 116.1M | 236.7M | 156.4M | 26.7M |
Operating Margin % | 19.0% | 14.2% | 23.5% | 19.8% | 4.8% |
Non-Operating Items | |||||
Interest Income | 33.5M | 20.4M | 5.0M | 1.2M | 2.9M |
Interest Expense | - | - | - | - | - |
Other Non-Operating Income | -145.0K | -3.9M | -141.0K | -1.9M | -2.7M |
Pre-tax Income | 220.4M | 132.6M | 241.6M | 155.7M | 26.9M |
Income Tax | 18.8M | 11.4M | 18.2M | 13.3M | -4.2M |
Effective Tax Rate % | 8.5% | 8.6% | 7.6% | 8.6% | -15.5% |
Net Income | 201.7M | 121.2M | 223.3M | 142.3M | 31.0M |
Net Margin % | 20.4% | 14.9% | 22.2% | 18.0% | 5.6% |
Key Metrics | |||||
EBITDA | 249.7M | 187.4M | 301.4M | 224.2M | 97.3M |
EPS (Basic) | $4.09 | $2.47 | $4.52 | $2.89 | $0.63 |
EPS (Diluted) | $4.06 | $2.46 | $4.49 | $2.86 | $0.63 |
Basic Shares Outstanding | 49343000 | 48971000 | 49424000 | 49242000 | 49136000 |
Diluted Shares Outstanding | 49343000 | 48971000 | 49424000 | 49242000 | 49136000 |
Income Statement Trend
Onto Innovation Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 212.9M | 233.5M | 175.9M | 169.6M | 136.7M |
Short-term Investments | 639.4M | 464.3M | 371.9M | 341.7M | 237.0M |
Accounts Receivable | 308.1M | 226.6M | 241.4M | 177.2M | 149.3M |
Inventory | 287.0M | 327.8M | 324.3M | 243.1M | 191.2M |
Other Current Assets | 30.1M | 31.1M | 21.4M | 16.4M | - |
Total Current Assets | 1.5B | 1.3B | 1.1B | 948.1M | 731.7M |
Non-Current Assets | |||||
Property, Plant & Equipment | 13.9M | 18.4M | 20.7M | 17.5M | 19.7M |
Goodwill | 787.4M | 799.0M | 853.8M | 908.9M | 931.6M |
Intangible Assets | 127.5M | 167.4M | 222.2M | 277.3M | 318.4M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 44.3M | 21.3M | 9.3M | 9.0M | 3.9M |
Total Non-Current Assets | 639.6M | 626.4M | 660.0M | 701.7M | 736.5M |
Total Assets | 2.1B | 1.9B | 1.8B | 1.6B | 1.5B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 56.3M | 49.9M | 54.5M | 53.3M | 40.2M |
Short-term Debt | 5.4M | 5.5M | 5.7M | 4.0M | 4.5M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 4.0M | 7.0M | 3.9M | 7.5M | 3.6M |
Total Current Liabilities | 170.1M | 147.7M | 160.6M | 154.5M | 120.1M |
Non-Current Liabilities | |||||
Long-term Debt | 9.7M | 14.0M | 16.3M | 13.8M | 16.5M |
Deferred Tax Liabilities | 4.0K | 0 | 7.4M | 40.3M | 55.6M |
Other Non-Current Liabilities | 7.4M | 9.0M | 11.3M | 13.5M | 10.0M |
Total Non-Current Liabilities | 21.1M | 25.5M | 37.9M | 69.2M | 83.3M |
Total Liabilities | 191.2M | 173.2M | 198.4M | 223.8M | 203.4M |
Equity | |||||
Common Stock | 49.0K | 49.0K | 49.0K | 49.0K | 49.0K |
Retained Earnings | 664.6M | 482.4M | 362.8M | 168.5M | 26.2M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.9B | 1.7B | 1.6B | 1.4B | 1.3B |
Key Metrics | |||||
Total Debt | 15.2M | 19.5M | 22.0M | 17.7M | 20.9M |
Working Capital | 1.3B | 1.1B | 974.3M | 793.6M | 611.6M |
Balance Sheet Composition
Onto Innovation Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 201.7M | 121.2M | 223.3M | 142.4M | 31.0M |
Depreciation & Amortization | 62.3M | 67.2M | 64.7M | 65.8M | 67.6M |
Stock-Based Compensation | 28.6M | 25.5M | 24.4M | 19.5M | 17.7M |
Working Capital Changes | -54.4M | -7.2M | -162.9M | -71.6M | -58.0M |
Operating Cash Flow | 212.4M | 187.3M | 115.4M | 146.2M | 62.0M |
Investing Activities | |||||
Capital Expenditures | -31.9M | -19.8M | -18.4M | -12.0M | -3.8M |
Acquisitions | -26.8M | 0 | -4.6M | -23.8M | 0 |
Investment Purchases | -708.7M | -480.5M | -371.3M | -361.0M | -313.0M |
Investment Sales | 540.8M | 396.8M | 338.6M | 255.1M | 265.4M |
Investing Cash Flow | -226.5M | -103.4M | -55.7M | -141.8M | -48.6M |
Financing Activities | |||||
Share Repurchases | -25.1M | -3.2M | -65.3M | 0 | -52.0M |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | -44.9M | -14.8M | -76.4M | -7.4M | -53.7M |
Free Cash Flow | 213.8M | 149.4M | 118.3M | 163.2M | 102.2M |
Net Change in Cash | -59.0M | 69.1M | -16.7M | -3.0M | -40.3M |
Cash Flow Trend
Onto Innovation Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
26.62
Forward P/E
16.03
Price to Book
2.68
Price to Sales
5.09
PEG Ratio
-0.75
Profitability Ratios
Profit Margin
19.29%
Operating Margin
19.10%
Return on Equity
10.53%
Return on Assets
6.31%
Financial Health
Current Ratio
9.59
Debt to Equity
0.68
Beta
1.44
Per Share Data
EPS (TTM)
$4.04
Book Value per Share
$40.12
Revenue per Share
$21.05
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
onto | 5.3B | 26.62 | 2.68 | 10.53% | 19.29% | 0.68 |
Applied Materials | 131.7B | 19.59 | 6.72 | 35.63% | 23.88% | 32.11 |
Lam Research | 125.1B | 23.82 | 12.72 | 58.24% | 29.07% | 48.23 |
Nova | 7.3B | 33.88 | 6.69 | 24.23% | 29.10% | 19.08 |
Amkor Technology | 5.9B | 19.48 | 1.40 | 7.35% | 4.80% | 42.84 |
Camtek | 3.8B | 30.75 | 6.12 | 24.28% | 28.36% | 31.68 |
Financial data is updated regularly. All figures are in the company's reporting currency.